Mark R. Witmer
Bristol-Myers Squibb (Germany)(DE)Bristol-Myers Squibb (Sweden)(SE)Bristol-Myers Squibb (Belgium)(BE)
Publications by Year
Research Areas
Protein Kinase Regulation and GTPase Signaling, HIV/AIDS drug development and treatment, Biochemical and Molecular Research, Cellular transport and secretion, Hepatitis C virus research
Most-Cited Works
- → Dissection of the Endogenous Cellular Pathways of PCSK9-induced Low Density Lipoprotein Receptor Degradation(2009)265 cited
- → Pharmacologic Profile of the Adnectin BMS-962476, a Small Protein Biologic Alternative to PCSK9 Antibodies for Low-Density Lipoprotein Lowering(2014)128 cited
- → Tyrosine Kinase 2-mediated Signal Transduction in T Lymphocytes Is Blocked by Pharmacological Stabilization of Its Pseudokinase Domain(2015)115 cited
- → 2-Aryl-2,2-difluoroacetamide FKBP12 Ligands: Synthesis and X-ray Structural Studies(2001)103 cited
- → Discovery and Preclinical Characterization of the Cyclopropylindolobenzazepine BMS-791325, A Potent Allosteric Inhibitor of the Hepatitis C Virus NS5B Polymerase(2014)99 cited
- → Decrypting the Biochemical Function of an Essential Gene from Streptococcus pneumoniae Using ThermoFluor® Technology(2005)55 cited